Compugen (CGEN) Assets Average (2009 - 2026)
Compugen's (CGEN) quarterly Assets Average came in at $151.2 million in Q1 2026, up 31.24% year-on-year from $115.2 million in Q1 2025, and up 18.87% quarter-over-quarter from $127.2 million in Q4 2025.
Compugen (CGEN) Assets Average (2009 - 2026) Analysis & Trends
Compugen has disclosed Assets Average across 18 years of filings, most recently posting $151.2 million for Q1 2026.
- Assets Average for Q1 2026 came in at $151.2 million, up 31.24% year-over-year; the trailing twelve-month figure through Mar 2026 was $151.2 million (up 31.24% YoY), and the FY2025 annual result was $135.8 million, up 14.91% from the prior year.
- Assets Average came in at $151.2 million for Q1 2026 at Compugen, up from $127.2 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $151.2 million in Q1 2026 to a low of $72.3 million in Q3 2023.
- The 5-year median for Assets Average is $111.9 million (2024), against an average of $109.0 million.
- Across the five-year window, Assets Average plunged 31.01% in 2023 and surged 61.53% in 2024, its largest moves.
- Compugen's Assets Average stood at $96.8 million in 2022, then slipped by 2.38% to $94.5 million in 2023, then advanced by 26.23% to $119.3 million in 2024, then gained by 6.67% to $127.2 million in 2025, then gained by 18.87% to $151.2 million in 2026.
- The last three Assets Average figures came in at $151.2 million (Q1 2026), $127.2 million (Q4 2025), and $102.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 33.42 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 795.91 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13.04 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.72 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 26.03 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 40.89 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 10.06 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 26.06 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 660.38 Mn |
| 10 | Compugen | 189.59 Mn | 97.83 Mn | 352,000.00 | 151.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 151.22 Mn |
| Dec 31, 2025 | 127.21 Mn |
| Sep 30, 2025 | 102.19 Mn |
| Jun 30, 2025 | 110.98 Mn |
| Mar 31, 2025 | 115.22 Mn |
| Dec 31, 2024 | 119.26 Mn |
| Sep 30, 2024 | 116.84 Mn |
| Jun 30, 2024 | 111.93 Mn |
| Mar 31, 2024 | 117.52 Mn |
| Dec 31, 2023 | 94.47 Mn |
| Sep 30, 2023 | 72.33 Mn |
| Jun 30, 2023 | 80.69 Mn |
| Mar 31, 2023 | 89.25 Mn |
| Dec 31, 2022 | 96.77 Mn |
| Sep 30, 2022 | 104.84 Mn |
| Jun 30, 2022 | 115.62 Mn |
| Mar 31, 2022 | 126.55 Mn |
| Dec 31, 2021 | 126.73 Mn |
| Sep 30, 2021 | 122.06 Mn |
| Jun 30, 2021 | 126.40 Mn |